SGAM
SGMO

Smith Group Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Smith Group Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,459
Closed -$164K – 426
2015
Q1 		$164K Sell
10,459
-76,180
-88% -$1.18M 0.01% 280
2014
Q4 		$1.32M Buy
86,639
+1,080
+1% +$13.1K 0.05% 166
2014
Q3 		$923K Buy
85,559
+369
+0.4% +$4.82K 0.03% 180
2014
Q2 		$1.3M Buy
+85,190
New +$1.23M 0.05% 172

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Smith Group Asset Management's SGMO Position: Q2 2015 in Review

Smith Group Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2015, closing a stake of 10,459 shares — an estimated $164K sold.

Smith Group Asset Management first reported a position in SGMO in Q2 2014 and held it in 4 quarters. The position peaked at $1.32M in Q4 2014. 156 funds tracked by Wall St. Rank hold SGMO as of Q2 2015.

  • Smith Group Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2015 after selling out during the quarter.
  • Smith Group Asset Management sold 10,459 SANGAMO THERAPEUTICS INC shares in Q2 2015, an estimated $164K.
  • Smith Group Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 4 quarters.
  • Smith Group Asset Management's SANGAMO THERAPEUTICS INC position peaked at $1.32M in Q4 2014.
  • 156 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2015.

Based on Smith Group Asset Management's 13F filing for Q2 2015, filed 29 Jul 2015.